Provided by Tiger Trade Technology Pte. Ltd.

Travere Therapeutics, Inc.

66.17
-1.3400-1.98%
Post-market: 66.170.00000.00%19:30 EDT
Volume:1.15M
Turnover:76.94M
Market Cap:6.24B
PE:-138.88
High:68.73
Open:67.76
Low:66.11
Close:67.51
52wk High:68.73
52wk Low:22.06
Shares:94.26M
Float Shares:92.77M
Volume Ratio:0.91
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4764
EPS(LYR):-0.2864
ROE:-236.35%
ROA:-3.73%
PB:254.35
PE(LYR):-231.08

Loading ...

3 Stocks Possibly Trading Below Estimated Value

Simply Wall St.
·
May 13

Travere Therapeutics grants inducement equity awards covering 48,800 shares to new hires

Reuters
·
May 13

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 13

Travere Therapeutics plans offering of $400 million convertible senior notes due 2032

Reuters
·
May 12

Travere Therapeutics Inc - Offers $475 Mln of 0.50% Convertible Senior Notes Due 2032 - SEC Filing

THOMSON REUTERS
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

BUZZ-Travere Therapeutics climbs after upsized $475 mln convertible financing

Reuters
·
May 07

BRIEF-Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering To Refinance 2029 Convertible Notes

Reuters
·
May 07

Travere prices upsized USD 475 million convertible senior notes due 2032

Reuters
·
May 07

Travere Therapeutics director Roy D. Baynes sells 4,500 shares for $209,925

Reuters
·
May 07

Travere CMO Jula Inrig disposes 22,485 shares for $1.01 million

Reuters
·
May 07

Travere Therapeutics CLO Elizabeth Reed disposes of shares worth $1.1 million

Reuters
·
May 07

Travere CFO Christopher R. Cline disposes 2,491 shares worth $115,287.45

Reuters
·
May 07

Travere Therapeutics director Jeffrey A. Meckler disposes 8,000 shares for $360,000

Reuters
·
May 07

Wells Fargo Remains a Buy on Travere Therapeutics (TVTX)

TIPRANKS
·
May 06

Travere Therapeutics announces $400M convertible senior notes offering

TIPRANKS
·
May 06

Travere Therapeutics plans USD 400 million convertible senior notes offering due 2032

Reuters
·
May 06

Travere Therapeutics Inc - to Offer $400 Mln Convertible Senior Notes Due 2032

THOMSON REUTERS
·
May 06

Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

THOMSON REUTERS
·
May 06

Evercore ISI Keeps Their Buy Rating on Travere Therapeutics (TVTX)

TIPRANKS
·
May 05